Bacteria News and Research

RSS

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Scientists from the Victor Chang Cardiac Research Institute (VCCRI), Sydney, have discovered the secrets behind the tiny motors in bacteria that allow them to swim rapidly towards nutrients and away from toxins, which is crucial to the spread of bacterial infection. These motors can rotate at up to 100,000 revolutions per minute, yet can switch directions in milliseconds.

1 Aug 2010

Stop & Shop Supermarket announces voluntary recall of Nature's Promise Alfalfa, Zesty Sprouts

The Stop & Shop Supermarket Company has announced a voluntary recall of Nature's Promise Alfalfa and Zesty Sprouts because they have the potential to be contaminated with listeria monocytogenes.

31 Jul 2010

WHO expert: Faster MDR-TB test should be made available to vulnerable populations

A new diagnostic tool that shortens the diagnosis of multidrug-resistant tuberculosis (MDR-TB) from eight weeks to two hours should be made available to vulnerable populations according to a WHO expert, Reuters reports.

31 Jul 2010

Resveratrol suppresses inflammation in humans: Research

Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.

31 Jul 2010

Down the silk road of the future

The Science paper notes that the development of silk hydrogels, films, fibers and sponges is making possible advances in photonics and optics, nanotechnology, electronics, adhesives and microfluidics, as well as engineering of bone and ligaments. Because silk fiber formation does not rely on complex or toxic chemistries, such materials are biologically and environmentally friendly, even able to integrate with living systems.

30 Jul 2010

Resveratrol suppresses inflammation and free radicals: Study

30 Jul 2010

Researchers discover three disease-causing genes in Salmonella

Researchers have discovered a novel mechanism in Salmonella that affects its virulence and its susceptibility to antibiotics by changing its production of proteins in a previously unheard of manner. This allows Salmonella to selectively change its levels of certain proteins to respond to inhospitable conditions.

30 Jul 2010

GSK exercises option to obtain exclusive licence to develop, commercialise GSK '052

Anacor Pharmaceuticals and GlaxoSmithKline PLC today announced that GSK has exercised its option to obtain an exclusive licence to develop and commercialise GSK2251052 (GSK '052), formerly known as AN3365. GSK '052 is a novel, systemic antibiotic derived from Anacor's boron chemistry platform.

30 Jul 2010

White button mushrooms can keep the immune system healthy: Study

Mushrooms are among the many foods thought to play an important role in keeping the immune system healthy. Now, Agricultural Research Service funded scientists have conducted an animal-model and cell-culture study showing that white button mushrooms enhanced the activity of critical cells in the body's immune system.

30 Jul 2010

New paradigm in TB research may lead to improved vaccination, treatment

Often causing no symptoms in carriers of the disease, worldwide tuberculosis (TB) infects eight to ten million people every year, kills two million, and it is highly contagious as it is spread through coughing and sneezing. "It's a global health disaster waiting to happen, even here in Canada, but this new paradigm in TB research may offer an immediate opportunity to improve vaccination and treatment initiatives," explains Dr. Maziar Divangahi of McGill University and of the Research Institute of the McGill University Health Centre.

30 Jul 2010

Researchers unveil mechanism of cholera bacteria to create cell energy

Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.

29 Jul 2010

Use of nanomaterials in construction poses potential environmental and health risks

Nanomaterials are poised for widespread use in the construction industry, where they can offer significant advantages for a variety of applications ranging from making more durable concrete to self-cleaning windows. But widespread use in building materials comes with potential environmental and health risks when those materials are thrown away. Those are the conclusions of a new study published by Rice University engineering researchers this month in ACS Nano.

29 Jul 2010

Nanotechnology approaches to solve major problems on global scale: Report

Nanotechnology refers to a broad range of tools, techniques and applications that simply involve particles on the approximate size scale of a few to hundreds of nanometers in diameter. Particles of this size have some unique physicochemical and surface properties that lend themselves to novel uses. Indeed, advocates of nanotechnology suggest that this area of research could contribute to solutions for some of the major problems we face on the global scale such as ensuring a supply of safe drinking water for a growing population, as well as addressing issues in medicine, energy, and agriculture.

29 Jul 2010

Mobile phones dirtier than we thought: Study

According to research for a UK consumer group mobile phones can harbor 18 times more living bacteria than a lavatory seat. For the study a hygiene expert swabbed and analysed 30 handsets and found seven had high levels of environmental bacteria.

28 Jul 2010

New study on treating CP with HBOT is making waves in India, U.S.

A new study on treating Cerebral Palsy with Hyperbaric Oxygen Therapy is making waves in India and the U.S. The largest sample of children studied to assess neuro-developmental improvements focuses on a combination of standard rehabilitation therapies, such as Occupational, Physical, Speech Therapies and HBOT.

28 Jul 2010

EFINTD awards 850,000 Euros for medical research on neglected tropical diseases in Africa

More than one billion people all over the world suffer from tropical diseases which are mostly unknown to the wider public and have also been neglected economically. In a joint effort with four other European foundations, the Volkswagen Foundation has opened a second round of funding for African scientists conducting research on these neglected diseases.

27 Jul 2010

Advanced Life Sciences enters agreement with UBC to develop antimicrobial peptides

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has entered into a sponsored research and option agreement with The University of British Columbia (UBC) to develop several antimicrobial peptides.

27 Jul 2010

Abbot's innovative solutions to be highlighted at AACC

A first-of-its-kind test that detects HIV infection earlier than ever before in the United States; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow improvements; are among the many new advances Abbott will highlight at this year's American Association for Clinical Chemistry Lab Expo which starts today in Anaheim.

27 Jul 2010

Study on interactions between new antitubercular drug candidates SQ109 and TMC207

Sequella, Inc., a clinical-stage biopharmaceutical company developing drugs for treatment of life-threatening infectious diseases, announced today the publication of studies in the scientific journal Antimicrobial Agents and Chemotherapy on synergy between SQ109, its lead drug candidate for the treatment of TB, and TMC207, Tibotec lead TB drug candidate:

27 Jul 2010

Scientists find MODS technique most accurate for testing tuberculosis in children

An international team of researchers comparing recently-developed methods for diagnosing tuberculosis in children in resource-poor countries has concluded that the best test for high-risk children is the microscopic-observation drug-susceptibility (MODS) technique using two gastric aspirate specimens from each child tested. MODS detects the presence of bacteria causing tuberculosis using microscopes to detect typical growth patterns in culture broth.

27 Jul 2010

Bacteria News and Research

Australian scientists uncover the secrets behind one of nature’s most extraordinary biological machines

Stop & Shop Supermarket announces voluntary recall of Nature's Promise Alfalfa, Zesty Sprouts

WHO expert: Faster MDR-TB test should be made available to vulnerable populations

Resveratrol suppresses inflammation in humans: Research

Down the silk road of the future

Resveratrol suppresses inflammation and free radicals: Study

Researchers discover three disease-causing genes in Salmonella

GSK exercises option to obtain exclusive licence to develop, commercialise GSK '052

White button mushrooms can keep the immune system healthy: Study

New paradigm in TB research may lead to improved vaccination, treatment

Researchers unveil mechanism of cholera bacteria to create cell energy

Use of nanomaterials in construction poses potential environmental and health risks

Nanotechnology approaches to solve major problems on global scale: Report

Mobile phones dirtier than we thought: Study

New study on treating CP with HBOT is making waves in India, U.S.

EFINTD awards 850,000 Euros for medical research on neglected tropical diseases in Africa

Advanced Life Sciences enters agreement with UBC to develop antimicrobial peptides

Abbot's innovative solutions to be highlighted at AACC

Study on interactions between new antitubercular drug candidates SQ109 and TMC207

Scientists find MODS technique most accurate for testing tuberculosis in children

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News